The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

BACKGROUND: Previous studies have reported up to 50% of ductal carcinoma in situ (DCIS), is HER2 positive, but the frequency of HER2-positive invasive breast cancer (IBC) is lower. The aim of this study is to characterise HER2 status in DCIS and assess its prognostic value. METHODS: HER2 status was...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Cancer
Glavni autori: Miligy, Islam M., Toss, Michael S., Gorringe, Kylie L., Lee, Andrew H. S., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738110/
https://ncbi.nlm.nih.gov/pubmed/31065110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0436-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items